Delivery Order SPE2DB24D9238-SPE2DB24FDQKF
Award Date
7/9/24
Potential Completion Date
7/30/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,003.02 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, with a completion date of March 4, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense Logistics Agency for the supply of a broad...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,004.53 firm fixed-price contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This contract is not set aside and is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,003.02 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $2,003.02 contract is for the supply of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a potential value of $2,003.02 and a completion date of February 22, 2024. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA, contract number 4600082013 under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a potential value of $3,004.53 and a completion date of March 7, 2024. This delivery order is likely part of DMS Pharmaceutical Group's broader indefinite delivery contract with DLA, contract 4600082013 under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,006.04 and is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. The contract has a period of performance through May 9, 2024 and does not have a set-aside designation. This delivery order contract is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,004.53 contract is for the delivery of Ozurdex 0.7 mg implants, a specialty ophthalmic medication. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This single-award...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $2,003.02, is for the delivery of OZURDEX 0.7 MG IMPLANTS. This delivery order is part of a larger indefinite delivery contract, SPE2DB, held by DMS Pharmaceutical Group with the DLA, valued at up to $4,999,999 through the end of 2025. The contract has no set-aside...
The U.S. government awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 contract, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division, is to provide OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract...